ID 2455 - Justicia gendarussa

PL: Justicia gendarussa
EN: Justicia gendarussa
Pdf: Justicia gendarussa L.

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituent that is the subject of the health claim is Justicia gendarussa L.. The characterisation of Justicia gendarussa L. is performed by comparing data provided as conditions of use to information extracted from standard reference textbooks (see Table 2 below and Appendix C for list of standard reference textbooks used for the characterisation).
Table 2. Information on Justicia gendarussa L. from standard reference textbooks and the information provided as conditions of use.
ID Scientific name Part used Nature of the
preparation
Conditions of use
Text-
book Justicia gendarussa L. =
Gendarussa vulgaris
(Nees.)
Acanthaceae
Leaf; root Decoction;
infusion
No information found
2455 Justicia gendarussa Leaf Not specified.
Note: it is
assumed to be
the dried form.
Leaf: 800-1600mg / Used as part
of a multibotanical combination.
Note: the daily amount is not
specified.
The nature of the preparation is not specified, but it is assumed to be dried leaf. The daily amount is not specified. The Panel notes that the consolidated list contains insufficient information to allow a characterisation of Justicia gendarussa L..
The Panel notes that there is no information on the other components of the multibotanical combination.
The Panel considers that the food constituent, Justicia gendarussa L., which is the subject of the health claims, has not been sufficiently characterised.

2.1. Poprawa diurezy (funkcji nerek) (ID 2455)

The claimed effect is “health of lower urinary tract”. The Panel assumes that the target population is the general population.
“Health of lower urinary tract” is not sufficiently defined. From the proposed wordings the Panel assumes that the claimed effect relates to improvement of diuretic function.
The Panel considers that no evidence has been provided to establish that improvement of diuretic function is beneficial to human health of the general population.

2.2. Ograniczenie zapalenia dolnych dróg moczowych (ID 2455)

The claimed effect is “health of lower urinary tract”. The Panel assumes that the target population is the general population.
“Health of lower urinary tract” is not sufficiently defined. From the proposed wordings the Panel assumes that the claimed effect relates to reduction of inflammation of the lower urinary tract.
The Panel considers that reduction of inflammation of the lower urinary tract might be beneficial to human health.

3.1. Poprawa diurezy (funkcji nerek) (ID 2455)

One reference was cited to substantiate the claimed effect. This reference is a web site, in which the claimed effect is stated. The Panel notes that the reference cited did not provide any scientific data that could be used to substantiate the claimed effect.
The Panel concludes that a cause and effect relationship has not been established between the consumption of Justicia gendarussa L. and improvement of diuretic function.

3.2. Ograniczenie zapalenia dolnych dróg moczowych (ID 2455)

One reference was cited to substantiate the claimed effect. This reference is a web site, in which the claimed effect is stated. The Panel notes that the reference cited did not provide any scientific data that could be used to substantiate the claimed effect.
The Panel concludes that a cause and effect relationship has not been established between the consumption of Justicia gendarussa L. and reduction of inflammation of the lower urinary tract.

Warunki i możliwe ograniczenia stosowania oświadczenia

Leaf: 800 - 1600 mg / Used as part of a multibotanical combination